SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

ABTSell

ABBOTT LABORATORIES

Robert B Ford · Chair and CEO

$46.2M−56.5%Aug 27
ABTSell

ABBOTT LABORATORIES

Louis H. Morrone · Executive VICE President

$643K−7.6%Aug 13
ABTSell

Abbott Laboratories

Mary K Moreland · EVP

$71K−1.0%Mar 3
ABTSell

Abbott Laboratories

Eric Shroff · SVP

$82K−2.0%Mar 3
ABTSell

Abbott Laboratories

Daniel Gesua Sive Salvadori · EVP, GROUP Pres

$102K−1.0%Mar 3
ABTSell

Abbott Laboratories

Louis H. Morrone · EVP

$132K−1.0%Mar 3
ABTSell

Abbott Laboratories

John A. Mccoy Jr. · VP, CONTROLLER

$68K−2.0%Mar 3
ABTSell

Abbott Laboratories

Eric Shroff · SVP

$203K−5.0%Nov 25
ABTSell

Abbott Laboratories

Hubert L Allen · EVP

$18.4M−46.0%Oct 23
ABTSell

Abbott Laboratories

Robert B Ford · Chair and CEO

$16.5M−25.0%Sep 13
ABTSell

Abbott Laboratories

Funck, Jr. Robert E. · EVP

$1.1M−4.0%May 14
ABTSell

Abbott Laboratories

Lisa D Earnhardt · EVP

$2.4M−27.0%May 8
ABTSell

Abbott Laboratories

Mary K Moreland · EVP

$80K−1.0%Mar 4
ABTSell

Abbott Laboratories

Daniel Gesua Sive Salvadori · EVP

$114K−1.0%Mar 4
ABTSell

Abbott Laboratories

Louis H. Morrone · EVP

$95K−1.0%Mar 4
ABTSell

Abbott Laboratories

John A. Mccoy Jr. · VP

$56K−2.0%Mar 4
ABTSell

Abbott Laboratories

Lisa D Earnhardt · EVP

$82K−1.0%Mar 4
ABTSell

Abbott Laboratories

Hubert L Allen · EVP

$101KMar 4
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$1.5M−14.0%Feb 27
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$4.8M−40.0%Jan 31
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$1.6M−19.0%Dec 18
ABTSell

Abbott Laboratories

Daniel J Starks · Director

$4.7M−1.0%Oct 30
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$1.1M−14.0%Aug 10
ABTSell

Abbott Laboratories

Daniel J Starks · Director

$5.7M−1.0%Jul 28
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$909K−10.0%May 3
ABTSell

Abbott Laboratories

Daniel J Starks · Director

$5.6M−1.0%May 2
ABTSell

Abbott Laboratories

Mary K Moreland · EVP

$72K−1.0%Mar 2
ABTSell

Abbott Laboratories

Randel William Woodgrift · SVP

$104K−2.0%Mar 2
ABTSell

Abbott Laboratories

Jared Watkin · SVP

$121K−2.0%Mar 2
ABTSell

Abbott Laboratories

Andrea F Wainer · EVP

$68K−1.0%Mar 2
ABTSell

Abbott Laboratories

Julie L. Tyler · SVP

$53K−1.0%Mar 2
ABTSell

Abbott Laboratories

Daniel Gesua Sive Salvadori · EVP

$109K−1.0%Mar 2
ABTSell

Abbott Laboratories

Louis H. Morrone · SVP

$110K−2.0%Mar 2
ABTSell

Abbott Laboratories

Joseph J Manning · EVP

$135K−2.0%Mar 2
ABTSell

Abbott Laboratories

John F Ginascol · EVP

$95K−1.0%Mar 2
ABTSell

Abbott Laboratories

Funck, Jr. Robert E. · EVP

$127KMar 2
ABTSell

Abbott Laboratories

Lisa D Earnhardt · EVP

$95K−1.0%Mar 2
ABTSell

Abbott Laboratories

Michael D Dale · SVP

$122K−3.0%Mar 2
ABTSell

Abbott Laboratories

Hubert L Allen · EVP

$108K−1.0%Mar 2
ABTSell

Abbott Laboratories

Gregory A Ahlberg · SVP

$133K−3.0%Mar 2
ABTSell

Abbott Laboratories

Julie L. Tyler · SVP

$27K−1.0%Feb 22
ABTSell

Abbott Laboratories

Sammy Karam · SVP

$457K−14.0%Jan 3
ABTSell

Abbott Laboratories

John F Ginascol · EVP

$1.2M−9.0%Dec 15
ABTSell

Abbott Laboratories

Daniel J Starks · Director

$4.9M−1.0%Oct 31
ABTSell

Abbott Laboratories

Joseph J Manning · EVP

$2.5M−30.0%Sep 9
ABTSell

Abbott Laboratories

Robert B Ford · Chair and CEO

$10.8M−23.0%Aug 26
ABTSell

Abbott Laboratories

Joseph J Manning · EVP

$2.8M−34.0%Aug 26
ABTSell

Abbott Laboratories

Daniel J Starks · Director

$5.5M−1.0%Jul 28
ABTSell

Abbott Laboratories

Fernando Mateus · SVP

$268K−14.0%Jul 27
ABTSell

Abbott Laboratories

Julie L. Tyler · SVP

$28K−1.0%Jul 27

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.